 | | PRD_002569 | | Name: | Rufomycin analog | | Formula: | C58 H87 Cl N9 O12 | | Definition date: | 2025-04-16 | | Last modified: | 2025-04-16 |
|
 | | PRD_002534 | | Name: | Inhibitor YBX-PHE-VAL-GLY-THR-THR-PHA-MAA-BIF-EME-NEH | | Formula: | C64 H84 N10 O14 S | | Definition date: | 2025-03-26 | | Last modified: | 2025-03-26 |
|
 | | PRD_002560 | | Name: | Entolysin A | | Formula: | C81 H141 N17 O23 | | Description: | D-Ser, L-Val, L-Leu, D-Ser, L-Ile amino acids make up a macrocycle within the peptide | | Definition date: | 2025-02-26 | | Last modified: | 2025-02-26 |
|
 | | PRD_002561 | | Name: | Orfamide A | | Formula: | C64 H114 N10 O17 | | Description: | Cyclic lipopeptide | | Definition date: | 2025-02-26 | | Last modified: | 2025-02-26 |
|
 | | PRD_002460 | | Formula: | C20 H39 N3 O5 | | Description: | Calpain I inhibitor | | Definition date: | 2021-02-24 | | Last modified: | 2025-02-04 |
|
 | | PRD_002363 | | Formula: | C73 H120 N20 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2025-02-04 |
|
 | | PRD_002397 | | Formula: | C41 H72 N14 O10 S | | Definition date: | 2021-03-31 | | Last modified: | 2025-02-04 |
|
 | | PRD_002398 | | Formula: | C42 H74 N14 O10 S | | Definition date: | 2021-03-31 | | Last modified: | 2025-02-04 |
|
 | | PRD_002399 | | Formula: | C45 H68 N10 O11 S | | Definition date: | 2021-03-31 | | Last modified: | 2025-02-04 |
|
 | | PRD_002111 | | Name: | ADEP-2B5Me | | Formula: | C41 H56 F2 N6 O8 | | Definition date: | 2014-10-08 | | Last modified: | 2024-12-19 |
|
 | | PRD_002551 | | Name: | Alisporivir | | Formula: | C63 H113 N11 O12 | | Description: | Analogue of cyclosporine A. It is a cyclic undecapeptide. Cyclization is achieved by linking the N- and the C- termini. | | Definition date: | 2024-10-30 | | Last modified: | 2024-10-30 |
|
 | | PRD_002553 | | Name: | Dihydrocyclosporin A | | Formula: | C62 H113 N11 O12 | | Description: | Analogue of cyclosporine A. It is a cyclic undecapeptide. Cyclization is achieved by linking the N- and the C- termini. | | Definition date: | 2024-10-30 | | Last modified: | 2024-10-30 |
|
 | | PRD_002519 | | Name: | MCR-PHE-VAL-PRO-THR-THR-BIF-MAA-BIF-MAA-GLU-ALA-PRO-ALA-NEH inhibitor | | Formula: | C85 H110 N14 O18 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002520 | | Name: | ACE-PHE-VAL-DAB-THR-THR-PHE-MAA-BIF-YBR inhibitor | | Formula: | C62 H80 N10 O14 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002521 | | Name: | YBX-YC3-VAL-PRO-THR-THR-PHE-MAA-CYS-MN1 inhibitor | | Formula: | C60 H81 N9 O13 S3 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002523 | | Name: | MCR-ALO-MAA-ALA-MAA-NLE-7T2-SER-7T2-ALA-NH2 inhibitor | | Formula: | C49 H70 Cl2 N10 O12 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002525 | | Name: | PPI-YD5-NLE-7T2-SER-7T2-DPP-GLY-NH2 inhibitor | | Formula: | C43 H59 Cl2 N9 O10 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002554 | | Name: | MCR-ALA-7T2-GLY-004-7T2-SER-7T2-0NC inhibitor | | Formula: | C52 H60 Cl3 N9 O10 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002558 | | Name: | DGN-DVA-YC3-GLU-PRO-THR-THR-PHE-MAA-A1BC0 inhibitor | | Formula: | C62 H84 N12 O14 S2 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002562 | | Name: | MCR-ALA-7T2-GLY-004-7T2-SER-7T2-ALA-GLY-NH2 inhibitor | | Formula: | C53 H61 Cl3 N10 O11 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002546 | | Name: | NOSO-95179 antibiotic | | Formula: | C43 H79 N18 O11 | | Definition date: | 2024-10-09 | | Last modified: | 2024-10-09 |
|
 | | PRD_002540 | | Name: | evybactin | | Formula: | C64 H91 N21 O21 | | Definition date: | 2024-10-02 | | Last modified: | 2024-10-02 |
|
 | | PRD_002234 | | Formula: | C57 H91 N12 O19 | | Definition date: | 2024-08-07 | | Last modified: | 2024-08-07 |
|
 | | PRD_000694 | | Name: | SYNTHETIC PEPTIDE PHQ-PRO-YCP | | Formula: | C19 H24 N2 O5 | | Definition date: | 2024-08-07 | | Last modified: | 2024-08-07 |
|
 | | PRD_000695 | | Name: | (2S)-1-[2-[(4-hydroxy-4-oxobutanoyl)amino]acetyl]pyrrolidine-2-carboxylic acid | | Formula: | C11 H16 N2 O6 | | Definition date: | 2024-08-07 | | Last modified: | 2024-08-07 |
|
